Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 373
7
Diseases
47
Unique genes
0.149
Avg. similarity score
Hemophagocytic lymphohistiocytosis
Most-connected disease (5 links)
Disease
Searched: Hemophagocytic lymphohistiocytosis, familial, 2
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Hemophagocytic lymphohistiocytosis, familial, 2
Hemophagocytic lymphohistiocytosis
Hereditary hemophagocytic lymphohistiocytosis
Autoinflammatory syndrome
Hemophagocytic lymphohistiocytosis, familial, 5, with or without microvillus inclusion disease
Congenital lactic acidosis
Immune dysregulation and systemic hyperinflammation syndrome
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Hemophagocytic lymphohistiocytosis | 5 | 5 | 9 |
| Hereditary hemophagocytic lymphohistiocytosis | 5 | 5 | 4 |
| Autoinflammatory syndrome | 3 | 3 | 39 |
| Hemophagocytic lymphohistiocytosis, familial, 2 | 3 | 3 | 1 |
| Hemophagocytic lymphohistiocytosis, familial, 5, with or without microvillus inclusion disease | 3 | 3 | 1 |
| Congenital lactic acidosis | 2 | 2 | 4 |
| Immune dysregulation and systemic hyperinflammation syndrome | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| STXBP2 | 5 / 7 | Autoinflammatory syndrome, Congenital lactic acidosis, Hemophagocytic lymphohistiocytosis, Hemophagocytic lymphohistiocytosis, familial, 5, with or without microvillus inclusion disease and 1 more |
| PRF1 | 4 / 7 | Autoinflammatory syndrome, Hemophagocytic lymphohistiocytosis, Hemophagocytic lymphohistiocytosis, familial, 2, Hereditary hemophagocytic lymphohistiocytosis |
| STX11 | 3 / 7 | Autoinflammatory syndrome, Hemophagocytic lymphohistiocytosis, Hereditary hemophagocytic lymphohistiocytosis |
| UNC13D | 3 / 7 | Autoinflammatory syndrome, Hemophagocytic lymphohistiocytosis, Hereditary hemophagocytic lymphohistiocytosis |
| RC3H1 | 2 / 7 | Hemophagocytic lymphohistiocytosis, Immune dysregulation and systemic hyperinflammation syndrome |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| NOD-like receptor signaling pathway | KEGG | 9 / 187 | 12.3× | 3.63e-8 | 2.03e-6 ✓ sig. |
| Regulation of TNFR1 signaling | Reactome | 4 / 33 | 31.0× | 7.75e-6 | 2.09e-4 ✓ sig. |
| The NLRP3 inflammasome | Reactome | 3 / 15 | 51.1× | 2.47e-5 | 5.51e-4 ✓ sig. |
| Cholesterol biosynthesis | Reactome | 3 / 21 | 36.5× | 7.11e-5 | 1.31e-3 ✓ sig. |
| Terpenoid backbone biosynthesis | KEGG | 3 / 23 | 33.3× | 9.42e-5 | 1.64e-3 ✓ sig. |
| Purinergic signaling in leishmaniasis infection | Reactome | 3 / 24 | 31.9× | 1.07e-4 | 1.82e-3 ✓ sig. |
| Yersinia infection | KEGG | 5 / 138 | 9.3× | 1.94e-4 | 2.92e-3 ✓ sig. |
| TNFR1-induced NFkappaB signaling pathway | Reactome | 3 / 30 | 25.6× | 2.12e-4 | 3.14e-3 ✓ sig. |
| Activation of gene expression by SREBF (SREBP) | Reactome | 3 / 42 | 18.3× | 5.79e-4 | 6.95e-3 ✓ sig. |
| NF-kappa B signaling pathway | KEGG | 4 / 105 | 9.7× | 7.37e-4 | 8.36e-3 ✓ sig. |
| RHO GTPases activate KTN1 | Reactome | 2 / 11 | 46.5× | 8.06e-4 | 8.96e-3 ✓ sig. |
| TNFR1-induced proapoptotic signaling | Reactome | 2 / 13 | 39.3× | 1.14e-3 | 1.16e-2 ✓ sig. |
| TNF signaling pathway | KEGG | 4 / 119 | 8.6× | 1.18e-3 | 1.19e-2 ✓ sig. |
| Neutrophil degranulation | Reactome | 7 / 480 | 3.7× | 2.45e-3 | 2.08e-2 ✓ sig. |
| Salmonella infection | KEGG | 5 / 248 | 5.2× | 2.73e-3 | 2.24e-2 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| pattern recognition receptor signaling pathway | GO:0002221 | 5 / 21 | 94.7× | 1.60e-9 | 3.25e-7 ✓ sig. |
| negative regulation of inflammatory response | GO:0050728 | 8 / 152 | 20.9× | 3.83e-9 | 7.09e-7 ✓ sig. |
| positive regulation of non-canonical NF-kappaB signal transduction | GO:1901224 | 6 / 66 | 36.1× | 1.47e-8 | 2.31e-6 ✓ sig. |
| inflammatory response | GO:0006954 | 10 / 467 | 8.5× | 1.95e-7 | 2.07e-5 ✓ sig. |
| regulation of inflammatory response | GO:0050727 | 6 / 106 | 22.5× | 2.57e-7 | 2.60e-5 ✓ sig. |
| immune system process | GO:0002376 | 13 / 943 | 5.5× | 3.60e-7 | 3.44e-5 ✓ sig. |
| positive regulation of interleukin-1 beta production | GO:0032731 | 5 / 66 | 30.1× | 6.44e-7 | 5.60e-5 ✓ sig. |
| innate immune response | GO:0045087 | 10 / 605 | 6.6× | 2.06e-6 | 1.45e-4 ✓ sig. |
| pigmentation | GO:0043473 | 4 / 39 | 40.8× | 2.71e-6 | 1.80e-4 ✓ sig. |
| pyroptotic inflammatory response | GO:0070269 | 4 / 40 | 39.8× | 3.00e-6 | 1.95e-4 ✓ sig. |
| nucleotide-binding oligomerization domain containing 2 signaling pathway | GO:0070431 | 3 / 14 | 85.2× | 5.32e-6 | 3.09e-4 ✓ sig. |
| positive regulation of inflammatory response | GO:0050729 | 5 / 122 | 16.3× | 1.35e-5 | 6.41e-4 ✓ sig. |
| defense response to bacterium | GO:0042742 | 6 / 214 | 11.1× | 1.53e-5 | 7.06e-4 ✓ sig. |
| isopentenyl diphosphate biosynthetic process, mevalonate pathway | GO:0019287 | 2 / 3 | 265× | 1.85e-5 | 8.18e-4 ✓ sig. |
| leukocyte mediated cytotoxicity | GO:0001909 | 2 / 3 | 265× | 1.85e-5 | 8.18e-4 ✓ sig. |